|
891 |
Mantelzelllymphom: Die wirkungsvollste ist nicht immer die beste Therapie
Enthalten in Karger-Kompass Onkologie Bd. 9, 2022, Nr. 3: 120-121. 2 S.
|
|
|
|
892 |
Efficacy and Safety of Sevelamer Carbonate in Chinese Nondialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized, Double-Blind, Parallel-Group Study
Enthalten in Kidney diseases Bd. 9, 2022, Nr. 2: 82-93. 12 S.
|
|
|
|
893 |
Mammakarzinom: Deutlicher Vorteil der Immuntherapie beim triple-negativen nicht-metastasierten Mammakarzinom
Enthalten in Karger-Kompass Onkologie Bd. 9, 2022, Nr. 2: 68-69. 2 S.
|
|
|
|
894 |
Influence of Sodium-Glucose Cotransporter-2 Inhibitors on Plasma Adiponectin in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
Enthalten in Hormone and metabolic research 01.09.2022
|
|
|
|
895 |
Therapie-assoziierte myeloische Neoplasien: Woran bei Blutbildveränderungen unter Therapie mit PARP-Inhibitoren gedacht werden sollte
Enthalten in Karger-Kompass Onkologie Bd. 9, 2022, Nr. 1: 20-21. 2 S.
|
|
|
|
896 |
A randomized, double-blind, placebo-controlled, cross-over pilot study to investigate the efficacy of Rest-ZZZ formula in healthy participants with occasional sleeplessness
Enthalten in Sleep and biological rhythms 22.8.2022: 1-10
|
|
|
|
897 |
Periarticular injection and hamstring block versus placebo for pain control in anterior cruciate ligament reconstruction: A randomized controlled trial
Enthalten in European journal of orthopaedic surgery & traumatology 19.8.2022: 1-7
|
|
|
|
898 |
Clinical Meaningfulness of Response to Tanezumab in Patients with Chronic Low Back Pain: Analysis From a 56-Week, Randomized, Placebo- and Tramadol-Controlled, Phase 3 Trial
Enthalten in Pain and therapy 13.8.2022: 1-19
|
|
|
|
899 |
Premedication with Simethicone for Improving the Quality of Gastric Mucosal Visualisation: A Double-blind Randomized Controlled Trial
Enthalten in Endoscopy International Open 11.08.2022
|
|
|
|
900 |
A Response to: Letter to the Editor Regarding Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Enthalten in Pain and therapy 10.8.2022: 1-2
|
|
Administration
